Skip to main content

Published locations for FDA OKs elacestrant for ESR1+ advanced, metastatic breast cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA OKs elacestrant for ESR1+ advanced, metastatic breast cancer

User login

  • Reset your password
  • /content/fda-oks-elacestrant-esr1-advanced-metastatic-breast-cancer
  • /internalmedicinenews/article/261009/metastatic-breast-cancer/fda-oks-elacestrant-esr1-advanced
  • /oncologypractice/article/261009/metastatic-breast-cancer/fda-oks-elacestrant-esr1-advanced
  • /hematology-oncology/article/261009/metastatic-breast-cancer/fda-oks-elacestrant-esr1-advanced
  • /internalmedicine/article/261009/metastatic-breast-cancer/fda-oks-elacestrant-esr1-advanced
  • /breast-cancer-icymi/article/261009/metastatic-breast-cancer/fda-oks-elacestrant-esr1-advanced